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CD4+ T cell regulation of CD25 expression controls
development of short-lived effector CD8+ T cells in
primary and secondary responses
Joshua J. Obara,1, Michael J. Molloyb,1, Evan R. Jellisona, Thomas A. Stoklaseka, Weijun Zhangb,
Edward J. Usherwoodb,2, and Leo Lefrançoisa,2
a
Department of Immunology, University of Connecticut Health Center, Farmington CT 06030; and bDepartment of Microbiology and Immunology, Dartmouth
Medical School, Lebanon NH 03756

Both CD4+ T cell help and IL-2 have been postulated to “program”
activated CD8+ T cells for memory cell development. However, the
linkage between these two signals has not been well elucidated.
Here we have studied effector and memory CD8+ T cell differentiation following infection with three pathogens (Listeria monocytogenes, vesicular stomatitis virus, and vaccinia virus) in the absence
of both CD4+ T cells and IL-2 signaling. We found that expression of
CD25 on antigen-speciﬁc CD8+ T cells peaked 3–4 days after initial
priming and was dependent on CD4+ T cell help, likely through a
CD28:CD80/86 mediated pathway. CD4+ T cell or CD25-deﬁciency
led to normal early effector CD8+ T cell differentiation, but a subsequent lack of accumulation of CD8+ T cells resulting in overall decreased memory cell generation. Interestingly, in both primary and
recall responses KLRG1high CD127low short-lived effector cells were
drastically diminished in the absence of IL-2 signaling, although memory precursors remained intact. In contrast to previous reports, upon
secondary antigen encounter CD25-deﬁcient CD8+ T cells were capable of undergoing robust expansion, but short-lived effector development was again impaired. Thus, these results demonstrated that CD4+
T cell help and IL-2 signaling were linked via CD25 up-regulation,
which controls the expansion and differentiation of antigen-speciﬁc
effector CD8+ T cells, rather than “programming” memory cell traits.
infection

| memory

lthough recent ﬁndings have advanced our knowledge of the
factors necessary to generate optimal memory CD8+ T cell
responses, a full understanding of the signals required remains
elusive. CD8+ T cell responses to acute viral or bacterial infections are characterized by three phases. Upon recognition of a
speciﬁc antigenic epitope, T cells undergo massive proliferation
and acquisition of effector functions. Pathogen-speciﬁc CD8+ T
cells can expand close to 105-fold from a population as small as a
few hundred precursors (1). These effector T cells have altered
chemokine and homing receptor expression enabling their migration through all peripheral tissues (2, 3). On further antigenic
stimulation, the effector CD8+ T cells will kill infected target
cells through several mechanisms thereby limiting pathogen
growth and dissemination. After this stage, effector CD8+ T cells
enter a contraction phase where a majority of the effector cells
undergo apoptosis leaving only 5–20% of the cells present at the
peak of expansion (4). The last stage is characterized by the
maintenance of a heterogeneous population of long-lived, stable
CD8+ memory T cells (5). These remaining cells are characterized as stem-cell like because they retain telomerase expression, the ability to self-renew, a high proliferative capacity,
and multipotency (5). In acute infections, the persistence of
these memory T cells relies on the presence of the common
gamma-chain (γc) cytokines IL-7 and IL-15 (6, 7). Upon secondary exposure to the speciﬁc antigen, memory CD8+ T cells
undergo a more rapid expansion and production of effector cy-
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tokines compared to the primary response, which results in rapid
control of infection.
Unfortunately, these cardinal rules of memory CD8+ T cell
function do not account for the extensive functional and phenotypic complexity of subsets that is known to exist (5). Additionally,
exactly when each subset differentiates from the original naïve
precursor remains controversial (8). Recent work has demonstrated that a single naïve antigen-speciﬁc CD8+ T cell can give rise
to all of the effector and memory subsets observed (9). One theory
suggests that heterogeneity occurs as early as the ﬁrst asymmetric
division of a naïve cell, where one daughter cell is “fated” to become effector-like through the up-regulation of effector molecules
and expression of differentiation markers. Meanwhile, the sister
cell retains the ability to differentiate into a memory-like cell (10).
It is unclear whether these lineages are set in stone or whether
manipulation of cell fate can occur through the presence or lack of
secondary stimulation. Recent evidence indicates the latter scenario is likely true because cells that have up-regulated granzyme B
(and therefore would be considered effector-like) maintained the
ability to form long-lived memory cells (11).
Population heterogeneity continues throughout the expansion
phase, as the ability to form memory cells can be correlated with
the expression patterns of CD127 and the killer cell lectin-like
receptor G1 (KLRG1) (12–14). Brieﬂy, KLRG1high CD127low
CD8+ T cells are considered to be more terminally differentiated
and die after clearance of the infection and therefore are referred to as short-lived effector cells (SLEC). KLRG1low
CD127high CD8+ T cells are referred to as memory precursor
effector cells (MPEC) because they possess effector properties,
but retain the ability to differentiate into a long-lived memory
population. The factors regulating the formation of the SLEC
and MPEC populations remain ill-deﬁned. It is well established
that three signals are necessary for the activation of naïve CD8+
T cells: (i) TCR stimulation, (ii) costimulation, and (iii) inﬂammatory cytokines (15), but how variations in these signals
may orchestrate effector and memory heterogeneity is not clear.
Interestingly, alterations in the amount of antigenic exposure do
not seem to skew effector cell differentiation, but the inﬂammatory
milieu is able to alter the SLEC/MPEC ratio (12, 14, 16).
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Results
CD4+ T Cell Help Is Critical for the Up-Regulation of CD25 by AntigenSpeciﬁc CD8+ T Cells. We wished to test whether a link exists between

CD4+ T cell help and CD25 expression by CD8+ T cells. To account
for potential variability between different systems, we examined
responses to LM or VSV expressing ovalbumin (LM-ova; VSVova), and VV-WR. C57BL/6 CD8+ T cells up-regulated CD25
transiently with peak expression at approximately 4 days after infection regardless of the pathogen studied (Fig. 1 A and B). In
contrast, pathogen-speciﬁc CD8+ T cells in mice treated with antiCD4 mAb or in MHC class II−/− mice only weakly up-regulated
CD25 (Fig. 1 A and B and Fig. S1). As past studies have shown that
CD40 deﬁcient mice have similar responses to helpless mice and
agonistic anti-CD40 antibodies can substitute for CD4+ T cell help,
we tested whether CD40−/− mice lacked the ability to up-regulate
CD25 (25, 29). Surprisingly, VV-speciﬁc CD8+ T cells from CD40deﬁcient animals expressed high levels of CD25, indistinguishable
from those in normal mice (Fig. 1C). In contrast, only minimal upregulation of CD25 was observed in CD8+ T cells from both CD28deﬁcient and CD80/86-deﬁcient mice (Fig. 1C). The decreased
194 | www.pnas.org/cgi/doi/10.1073/pnas.0909945107
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Based upon this, we explored whether other known regulators of
effector and memory CD8+ T cell differentiation, namely CD4+ T
cell help and IL-2 signaling, are critical for the development of
SLEC and MPEC populations.
Costimulatory signals driven by CD4+ T cells have been shown to
be crucial for the optimal differentiation of memory CD8+ T cells in
various models (17–19). However, controversy remains as to precisely when CD4+ T cell help is required for memory CD8+ T cell
differentiation. Depending on a number of variables in different
infection models, CD4+ T cells are required during priming,
maintenance, or recall and, in some cases, CD4+ T cell help can be
nonessential (17–21). An important variable that alters the requirement for CD4+ T cell help is the pathogen that is under study.
For example, the CD8+ T cell response to vesicular stomatitis virus
(VSV) infection is largely independent of CD4+ T cell help. In the
case of the CD8+ T cell response to Listeria monocytogenes (LM)
infection, some reports indicate a CD4+ T cell requirement for
primary expansion (21, 22) although others do not (18, 19). However, even when CD4+ T cell help is apparently not required for
primary expansion, the “helpless” memory CD8+ T cells respond
poorly to challenge (17–19), but there is disagreement in the literature on this point (21, 22). Additionally, in the absence of CD4+ T
cell help, immune responses to intranasal infection with vaccinia
virus-Western Reserve (VV-WR) or murine γ-herpesvirus generate
normal primary responses, but secondary recall is inhibited through
the up-regulation of PD-1 (23). Although the critical signal provided
by CD4+ T cell help appears to be the ligation of CD40 on antigen
presenting cells, IL-2 production by CD4+ T cells may also play a
role (24–26). Additionally, previous studies indicate that CD4+ T
cell help and IL-2 signaling during priming, although not shown to
be synonymous, are not required for the primary CD8+ T cell response to infection but are essential for the formation of a functional
memory population (27, 28). Nonetheless, the mechanism by which
CD4+ T cells impinge on CD8+ effector and memory T cell subset
development remains unclear.
The results presented here demonstrated that optimal differentiation of the SLEC population during primary and secondary
CD8+ T cell responses required the expression of CD25 and that
CD4+ T cell help, possibly through CD28 costimulation, regulated
the expression of CD25 on the pathogen-speciﬁc CD8+ T cells. Thus,
the helpless condition or the absence of CD25 resulted in a marked
reduction of the primary CD8+ T cell response that was largely restricted to the SLEC subset. However, the resulting memory CD8+ T
cells readily responded to secondary challenge. Our ﬁndings supported a role for CD4+ T cells in promoting IL-2 driven effector
CD8+ T cell expansion and survival, but do not support the notion
that these factors affect the functionality of memory CD8+ T cells.
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Fig. 1. CD4+ T cell help is required for the expression of CD25 by antigenspeciﬁc CD8+ T cells. (A) Time-course showing the percentage of B8R/Kbspeciﬁc CD8+ T cells expressing CD25 for mice infected with VV-WR in the
presence (blue) or absence (red) of CD4+ T cells for 7 days p.i. (B) Representative histograms show the peak expression of CD25 following infection
with VV-WR, LM-ova, or VSV-ova in the presence (blue line) or absence (red
line) of CD4+ T cells. Shaded histograms = isotype control. (C) Representative
histograms and time-course showing CD25 expression on B8R/Kb-speciﬁc
CD8+ T cells from intact (blue) or CD4-depleted WT mice (red), CD40−/− mice
(black), CD28−/− mice (green), or CD80/86−/− mice (orange) four days p.i.

CD25 expression could be a direct result of CD28:CD80/86 signals
but might also be a consequence of decreased IL-2 production because CD28:CD80/86 signals are known to regulate IL-2 expression
which in turn can regulate CD25 expression (30). To test this hypothesis, helpless mice were treated with 15,000U of rhIL-2 twice a
day and subsequently CD25 expression on day 4 after VV infection
was determined. Interestingly, rhIL-2 treatment was able to restore
CD25 expression by VV-speciﬁc CD8+ T cells (Fig. S2). Thus,
CD4+ T cell help plays an important role in regulating the expression of CD25 on pathogen-speciﬁc CD8+ T cells during infection potentially through CD28-CD80/86 mediated expression of
IL-2 from CD4+ T cells.
CD25 Expression Is Necessary for Optimal Expansion of CD8+ T Cells.

As helpless CD8+ T cells were unable to up-regulate CD25, we
examined whether primary responses were compromised in antiCD4 mAb treated mice. Following infection, antigen-speciﬁc
CD8+ T cells from all groups of mice underwent an initial robust
expansion, but responding CD8+ T cells from LM-ova and VVWR infected anti-CD4 mAb treated hosts were unable to sustain
expansion (Fig. 2 A and B). In contrast, CD4-depleted VSV-ova
infected mice mounted a primary response equivalent to that of
Obar et al.

% Ova/Kb-specific
CD8+ T cells

0.5

Day 5

Day 9

15

**

0.4
10

0.3
0.2

5

0.1

B
1.00
% B8R/Kb-specific
CD8+ T cells

A

B6

GK1.5

B6

% Ova/Kb-specific
CD8+ T cells

10

B

5

10
15
20
Day Post-Infection

25

30

WT
CD25-/WT (GK1.5)
CD25-/- (GK1.5)

5

0

0

5

10
15
20
Days Post Infection

25

30

Fig. 3. CD25-mediated signals are necessary for the optimal expansion of
effector CD8+ T cells. Time course showing the percentage of Ova/Kb-speciﬁc
CD8+ T cells (A) and B8R/Kb-speciﬁc CD8+ T cells (B) from the blood in mixed
bone marrow chimera mice infected with 103 CFU of LM-ova or 2 × 106 PFU
of VV-WR, respectively. The CD8+ T cell population was ﬁrst divided into WT
cells (blue) or CD25-deﬁcient cells (red) and then the percentage of antigenspeciﬁc CD8+ T cells was monitored longitudinally in the blood.

we tested whether CD25-deﬁciency affected the expansion of a
particular effector cell subpopulation after LM-ova or VV-WR
infection. Interestingly, before the peak of the responses (days 6/7)
effector cell differentiation was similar between WT and CD25deﬁcient CD8+ T cells. However, by the peak of the CD8+ T cell
response WT cells were predominantly found to have a SLEC
phenotype (KLRG1high CD127low), although CD25−/− pathogenspeciﬁc CD8+ T cells failed to accumulate the SLEC population
and had increased frequencies of EEC and MPEC populations
(Fig. 4 A–C and Fig. S7). Furthermore, the subset skewing of the
antigen-speciﬁc CD25−/− was maintained into the early memory
stages. Thus, although IL-2 signaling affected the overall expansion and survival of the responding CD8+ T cells, it appeared
that IL-2 was most critical for differentiation and expansion of the
SLEC subset.
IL-2 Drives Maximal Proliferation of Effector Cells Late in the
Response. To determine the reason for the impairment of

CD25−/− CD8+ T cells we measured cell proliferation by BrdU
incorporation. Mixed bone marrow chimeras (WT:CD25−/−) were
infected with LM-ova and the mice were treated with BrdU on
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Fig. 2. Early and late expansion of pathogen-speciﬁc CD8 T cells in helpless mice. C57BL/6 mice were either treated with anti-CD4 or left untreated. Mice were
subsequently infected with 103 CFU of Lm-ova (A), 2 × 106 PFU of VV-WR (B), or 105 PFU of VSV-ova (C) and tetramer+ splenic CD8+ T cells were monitored. These data
are representative of two independent experiments, each containing four to ﬁve mice per group. Statistical signiﬁcance was determined using a Student's t test.
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We next examined the role of IL-2 signaling in development of the
SLEC and MPEC populations. Expression of CD25 on SLEC and
MPEC Ova/Kb-speciﬁc CD8+ T cells was analyzed ﬁve days after
LM-ova infection. Furthermore, a third effector CD8+ T cell
population was observed at this time point, which was KLRG1low
CD127low [herein termed “early effector cells” (EEC)]. CD25
expression was greatest on the EEC subpopulation, with intermediate expression levels in the SLEC population, and the MPEC
population expressing the lowest CD25 levels (Fig. S6). Therefore,

25
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intact mice (Fig. 2C), conﬁrming previous studies (21). CD8+ T
cells in MHC class II−/− mice exhibited a similar phenomenon to
CD4-depleted mice in all cases (Fig. S1). Interestingly, optimal
expansion of VV-speciﬁc CD8+ T cells correlated with conditions that resulted in high levels of CD25 expression (Fig. S3).
To determine whether expression of CD25 was responsible for
the disparity between responses to different infections, we generated C57BL/6:CD25−/− mixed bone marrow chimeras as previously described (27, 28). The generation of mixed bone marrow
chimeras is necessary as CD25−/− mice develop autoimmunity and
lymphoproliferative disease at an early age due to the absence of
regulatory T cells (31). Chimeric mice were infected with LM-ova
or VV-WR and a kinetic analysis of peripheral-blood pathogenspeciﬁc CD8+ T cells was conducted. Although both populations of
CD8+ T cells expanded equivalently through days 4–6, the CD25−/−
cells failed to undergo sustained expansion and were rapidly outnumbered by the WT cells in all cases (Fig. 3 A and B), which is in
contrast to previously published reports (27, 28). A similar disparity
between the expansion of C57BL/6 cells and CD25−/− cells at the
peak of the LM-ova CD8+ T cell response was also observed in
lymphoid and peripheral tissues of infected mice, indicating that
this effect was not isolated to the peripheral blood (Fig. S4). Following VSV infection, the decreased response of CD25−/− cells was
substantially less severe than that observed for LM-ova and VVWR infection (Fig. S5). Nevertheless, SLEC development was
impaired, but because fewer SLEC developed after VSV infection
compared to LM infection, the overall response was less affected.
To examine whether the observations in the helpless mice and
CD25-deﬁcient cells were linked, we treated mixed chimeras with
CD4 depleting antibody. When CD4+ T cells were depleted from
chimeric mice infected with LM-ova, no statistical difference in
the percentage of Ova/Kb-speciﬁc cells was observed between
CD4-deﬁcient WT and CD25−/− cell populations (Fig. 3A). Similar results were observed for anti-CD4 treated VV-WR infected
chimeras during the expansion phase; however during the early
stages of the memory phase, a small but statistically signiﬁcant
difference between the percentage of B8R-speciﬁc WT and
CD25−/− CD8+ T cells in CD4-depleted mice was observed (Fig.
3B). Overall, these results suggested that decreased IL-2 signaling
in helpless mice, as a result of lower CD25 levels, was responsible
for the reduced accumulation of pathogen-speciﬁc CD8+ T cells.
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either day 4 or day 8. One day later, mice were killed and BrdU
incorporation into the splenic Ova/Kb-speciﬁc CD8+ T cells was
analyzed. WT and CD25−/− antigen-speciﬁc CD8+ T cells incorporated similar levels of BrdU from days 4 to 5 of the response
(Fig. 5A), at a time when CD25 expression is being up-regulated.
However, as the peak of the response approached on days 8 and 9,
WT antigen-speciﬁc CD8+ T cells incorporated signiﬁcantly more
BrdU than their CD25-deﬁcient counterparts (Fig. 5B). Thus, in
agreement with earlier studies (32), initial CD8+ T cell expansion
was IL-2 independent, although sustained proliferative expansion
and/or survival required CD25 expression.
CD25-Deﬁcient CD8+ T Cells Retain the Ability to Respond to
Secondary Challenges. To elucidate whether the CD25−/− mem-

ory population was capable of a secondary response, LM-ova
memory mice were restimulated with LM-ova, whereas VV-WR
196 | www.pnas.org/cgi/doi/10.1073/pnas.0909945107

memory chimeras were challenged with an attenuated LM-B8R.
Although fewer CD25−/− memory cells were present, due to the
reduced primary response, in both infections the CD25−/− CD8+
T cells were able to undergo a robust secondary expansion, which
was similar when compared to WT cells (Fig. 6 A and B).
To further examine the recall potential of the CD25-deﬁcient
pathogen-speciﬁc CD8+ T cells, memory CD8+ T cells from
chimeric mice were sorted into CD25−/− (CD45.2+) and WT
(CD45.1+) populations. After sorting, 1,000 Ova/Kb-speciﬁc
CD8+ T cells of each were mixed and transferred into naïve
C57BL/6 mice (CD45.1+ CD45.2+). One day after transfer, mice
were challenged with 2 × 103 CFU of LM-ova and 8 days later
the mice were killed and the absolute number of Ova/Kb-speciﬁc
CD8+ T cells of CD25−/− and WT origin was enumerated. Both
the WT and CD25-deﬁcient memory cells underwent substantial
secondary expansion, greater than 359-fold (WT) and greater
than 122-fold (CD25−/−) in the spleen, respectively (Fig. 6C).
Furthermore, when the secondary effector cells were divided
based on KLRG1 and CD127 expression, the SLEC population
was depressed within the CD25−/− cells, whereas the EEC and
MPEC subsets were increased, as was observed in the primary
response (Fig. 6C).
Discussion
CD4+ T cell help has been shown to be pivotal for primary or
secondary CD8+ T cell responses in numerous infection models.
However, perplexing discrepancies remain between models as to
the nature of the mechanisms that dictate the level of CD4+ T cell
dependency of a particular response. In addition, the CD4+ T cell
derived factor(s) that provide help to the CD8+ T cells may be
varied. Although CD40-mediated activation of DC may be one
mechanism to promote CD8+ T cell responses, IL-2 production
may also augment the CD8+ T cell response either alone or in
concert with CD40 signaling. For instance, no defect has been
observed for memory CD8+ T cells developing in the absence
of CD40 signaling during LM infection (33). In contrast, CD40
signaling appears to be critical for full differentiation of memory
CD8+ T cells following inﬂuenza A virus, murine γ-herpesvirus,
and intranasal vaccinia virus infections (23, 29). Our results
showed that the CD8+ T cell response to i.p. VV infection was
Obar et al.
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Fig. 6. CD25-deﬁcient memory CD8 T cells are able to mount a robust
secondary response. CD25−/−/WT mixed chimera mice were primed with 103
CFU of LM-ova (A) or 2 × 106 PFU of VV-WR (B) and left for more than 42
days and challenged with 5 × 104 CFU of LM-ova or 106 CFU of LM-B8R,
respectively. Mice were subsequently bled to monitor the magnitude of the
pathogen-speciﬁc CD8+ T cell response. Representative dot plots show the
prechallenge frequency of antigen-speciﬁc CD8+ T cells and the peak recall
response. The bar graph shows the average expansion of the pathogenspeciﬁc CD8+ T cells at the indicated times and relative fold expansion of
each population. (C) WT (CD45.1+) and CD25−/− (CD45.2+) CD8+ T cells were
puriﬁed by ﬂow cytometry and then 1,000 Ova/Kb-speciﬁc CD8+ T cells mixed
together and injected i.v. into naïve CD45.1+/CD45.2+ recipient mice. One
day later mice were challenged with 5 × 103 PFU of Lm-ova and the number
of Ova/Kb-speciﬁc CD8+ T cells was enumerated in the spleen and lungs on
day 8 postchallenge. Zebra plots are gated on the Ova/Kb-speciﬁc CD8+ T
cells of WT or CD25−/− origin and secondary effector cell subpopulations
were determined. Values represent the mean ± 1 SD from four mice and
data are representative of two independent experiments.

CD40 independent but required CD4+ T cells, IL-2, and CD28mediated costimulation (Fig. 1). CD4+ T cells and IL-2 were also
critical for driving normal primary CD8+ T cell responses to LM
and VV-WR infections (Figs. 2 and 3). Interestingly, CD4+ T cell
help and IL-2 were needed relatively late in the primary response
to promote proliferation and perhaps survival because early CD8+
T cell expansion occurred normally in the absence of CD4+ T cells
or CD25 but was followed by a more dramatic contraction phase
(Fig. 3). Thus, it is important to consider the overall kinetics of a
response when analyzing potentially controlling factors.
Our ﬁndings indicated that one mechanism by which CD4+ T cells
may provide help was through the control of the up-regulation of
CD25 expression by recently activated CD8+ T cells (Fig. 1). The
decreased CD25 expression could be a direct result of CD28:CD80/
86 signals but might also be a consequence of decreased IL-2 production in the absence of CD4+ T cells because IL-2 is known to
regulate CD25 expression (34). Both are likely the case as engagement of the CD28:CD80/86 pathway causes IL-2 expression (30) and
the provision rIL-2 in the absence of CD4+ T cell help resulted in upregulation of CD25 expression (Fig. S2 and ref. 34). Either way, in the
absence of CD4+ T cells, CD25 was poorly up-regulated on reObar et al.

sponding CD8+ T cells after VV, VSV, and LM infections. This is in
line with previous studies that have demonstrated that CD4+ T cell
help regulates CD25 expression on CD8+ T cells after HSV-1 infection (35) and DC vaccination (36) and correlated with the CD4+
T cell dependence of these responses. In contrast, previous studies
reported no CD4+ T cell or CD25 involvement in the primary CD8+
T cell response to LCMV and LM infections (18, 19, 27, 28), although other studies support a role for CD4+ T cells in primary
CD8+ T cell responses to these and other immunogens (21, 22).
Interestingly, the route of infection may also determine the necessity
of CD4+ T cell help because primary CD8+ T cell responses were
“help” independent when mice were infected i.n. with VV-WR (23),
but our current study demonstrated the primary response to i.p. infection with VV-WR was dependent on CD4+ T cell help (Fig. 2).
Interestingly, our data indicated that the early CD8+ T cell response
was independent of CD4+ T cell help and IL-2, whereas the continued differentiation and expansion typically required both (Figs. 3
and 5). Whether the necessary IL-2 for sustained CD8+ T cell expansion is derived solely from CD4+ T cells is not known. Our previous studies showed that autocrine CD8+ T cell produced IL-2 is not
required for maximal expansion but, in fact, appears to dampen the
overall magnitude of the response (32). Furthermore, work by Livingstone and colleagues demonstrated that CD4+ T cells provided
the major source of IL-2 for responding antigen-speciﬁc CD8+ T
cells (26). In either case, CD25 expression would be required to
mediate IL-2 effects and therefore CD4+ T cells would be involved in
the regulation of the CD8+ T cell response at multiple levels.
Recent work illustrates that substantial heterogeneity exists
within the effector CD8+ T cell population. Originally, memoryprecursors were identiﬁed by their retention of CD127 expression (37, 38), which has now been reﬁned to use KLRG1 and
CD127 expression to identify MPEC and SLEC (12–14), and, in
this report, EEC. Only recently have some of the factors regulating the differentiation of the MPEC and SLEC populations
been identiﬁed. Although earlier work demonstrated that TCR
or cytokine signaling alone were insufﬁcient to up-regulate
KLRG1 on T cells (39), recent work has shown that IL-12 signaling in the antigen-speciﬁc CD8+ T cells is important for
SLEC differentiation and this process is T-bet mediated (12).
Furthermore, inﬂammatory and IL-12 signaling events are temporally linked with TCR engagement (16). The transcription
factor Blimp1 has been found to be important in the generation
of SLEC (40, 41). Interestingly, Blimp1 expression is regulated
by IL-2 in vitro (42) and our data demonstrated that IL-2
mediated signals played an important role in regulating the
formation of the SLEC population (Fig. 4). Thus, IL-12 likely
mediates early events in the initial differentiation of the SLEC,
although IL-2, perhaps through enhancement of Blimp1 expression, acts at later times to further promote the differentiation of more SLECs, perhaps from EEC that express the
highest levels of CD25.
Our studies further demonstrated that CD25-deﬁcient pathogenspeciﬁc CD8+ T cells generated an MPEC population during the
effector stage, and these cells went on to form a stable, long-lived
memory pool (Figs. 3 and 4). Moreover, in the absence of IL-2 driven
signals, memory CD8+ T cells from LM and VV infected mice responded vigorously to a secondary challenge (Fig. 6). However,
SLEC development was again dampened just as we observed in the
primary response implicating IL-2 in modulation of the primary and
secondary responses through enhancing the late differentiation of
the SLEC population. Nevertheless, we found little evidence for a
helpless phenotype of memory CD8+ T cells that developed in the
absence of CD4+ T cells or CD25. Previous studies performed with
LCMV-speciﬁc P14 TCR transgenic CD8+ T cells lacking CD25
indicate that although cells are capable of proliferating during a
secondary response, their overall accumulation is impaired. The
authors attributed these ﬁndings to a potential increase in cell death
(27). In contrast, we observed robust expansion of CD25−/− CD8+ T
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cells during the secondary response at multiple time points. It is
possible that LCMV secondary responses are dependent upon IL-2
signals, although the infectious models we studied are not because
the LCMV results were conﬁrmed by a separate group (28). However, Williams et al. (27) also observed a defect in recall responses
to LM-ova in experiments that were very similar to our own. Although we cannot explain these discrepancies, the reproducibility of
our results in three separate infection models suggested that imprinting of proliferative capacity during the primary CD8+ T cell
response for the derived memory cells is not a generalizable phenomenon. Therefore, we conclude that CD4+ T cell help drives
CD25 up-regulation and this in turn allows IL-2 to enhance SLEC
differentiation during both primary and secondary CD8+ T cell responses, rather than acting as a “programmer” of the downstream
memory response.
Materials and Methods
Mice. All mice were used between 5 and 8 weeks of age for these studies. To
generate mixed bone marrow chimeras, B6-Ly5.2 recipient mice were lethally
irradiated with approximately 1,000 rads and subsequently injected i.v. with a
total of 106 bone marrow cells containing a mixture of CD25−/− and B6-Ly5.2
at a 2:1 ratio. Mice were left for at least 50 days before infection. All animal
protocols were approved by the Animal Care Committee at University of
Connecticut Health Center, Farmington, CT, and the Animal Care and Use
Program at Dartmouth College, Hanover, NH.

dary infections VV-WR memory mice were infected i.v. with 1 × 106 CFU of
attenuated (ActA- LLO-) LM expressing the B8R epitope (LM-B8R), whereas
both VSV-ova and LM-ova memory mice were challenged with 5 × 104 CFU
of LM-ova. CD4+ T cells were depleted as previously described (21, 23). To
supply exogenous IL-2, mice were treated with 15,000 U of recombinant
human IL-2 i.p., as previously performed (34).
Tissue Sample Preparation and Flow Cytometric Analysis. Mice were either
bled at the indicated time points or single cell suspensions of the indicated
tissues were prepared by collagenase digestion as previously described (2),
and cells were stained as previously described (1, 23). BrdU incorporation
was analyzed as previously described (1).
Adoptive Transfer and Recall of Memory CD8+ T Cells. WT (CD45.1) and CD25deﬁcient (CD45.2) memory CD8+ T cells were sorted on a FACSAria to >98%
purity. 1000 Ova/Kb-speciﬁc memory CD8+ T cells from each cell population
were mixed together and injected i.v. into naïve CD45.1/CD45.2 recipient mice.
One day later mice were challenged with 5 × 103 PFU of LM-ova and the
number of tetramer+ cells was enumerated in the spleen and lungs on day
8 postchallenge.
Statistical Analysis. Statistical signiﬁcance was determined by a Student's t
test using Prism 5. Signiﬁcance was set as any P value less than 0.05.

Experimental Treatment of Mice. Mice were infected with 105 PFU VSV-ova
(i.v.), 103 CFU LM-ova (i.v), or i.p. infection with 2 × 106 VV-WR. For secon-
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